Higher expression of toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 9, 2013, Pages 6012-6017

  Liu, Xiaoli ^a,b   Wang, Chaokui ^a   Ye, Zi ^a   Kijlstra, Aize ^c   Yang, Peizeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Behcet's disease; Il 17; TLR ligands; Toll like receptor

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; RESIQUIMOD; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFLAMMATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

BEHCET'S DISEASE; IL-17; TLR LIGANDS; TOLL-LIKE RECEPTOR;

ADULT; BEHCET SYNDROME; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4;

EID: 84883615696     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12159     Document Type: Article

References (35)

1. Deuter CM, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behcet's disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27:111-136.
2. Kurokawa MS, Yoshikawa H, Suzuki N. Behcet's disease. Semin Respir Crit Care Med. 2004;25:557-568.
3. Chi W, Zhou S, Yang P, Chen L. CD4+ T cells from Behcet patients produce high levels of IL-17. Yan Ke Xue Bao. 2011; 26:6-13.
4. Direskeneli H, Fujita H, Akdis CA. Regulation of TH17 and regulatory T cells in patients with Behcet disease. J Allergy Clin Immunol. 2011;128:665-666.
5. Geri G, Terrier B, Rosenzwajg M, et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol. 2011;128:655-664.
6. Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A. Expression of Th-17 and RORgammat mRNA in Behcet's Disease. Med Sci Monit. 2011;17:CR227-CR234.
7. Kim J, Park JA, Lee EY, Lee YJ, Song YW, Lee EB. Imbalance of Th17 to Th1 cells in Behcet's disease. Clin Exp Rheumatol. 2010;28:S16-S19.
8. Hatemi G, Bahar H, Uysal S, et al. The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis. 2004;63: 1450-1452.
9. Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y. Streptococcus oralis previously identified as uncommon 'Streptococcus sanguis' in Behcet's disease. Arch Oral Biol. 1995;40:685-690.
10. Ayaslioglu E, Duzgun N, Erkek E, Inal A. Evidence of chronic Chlamydia pneumoniae infection in patients with Behcet's disease. Scand J Infect Dis. 2004;36:428-430.
11. Direskeneli H, Mumcu G. A possible decline in the incidence and severity of Behcet's disease: implications for an infectious etiology and oral health. Clin Exp Rheumatol. 2010;28:S86-S90.
12. Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4({thorn}) T cells. J Exp Med. 2001;194:1711-1719.
13. Fang J, Fang D, Silver PB, et al. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest Ophthalmol Vis Sci. 2010;51:3092-3099.
14. Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol. 2002;3:499.
15. Kokkinopoulos I, Jordan WJ, Ritter MA. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol Immunol. 2005;42:957-968.
16. Marron TU, Martinez-Gallo M, Yu JE, Cunningham-Rundles C. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines. J Allergy Clin Immunol. 2012;129:184-190. e1-4.
17. Zarember KA, Godowski PJ. Tissue expression of human Tolllike receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 2002;168:554-561.
18. Dzopalic T, Rajkovic I, Dragicevic A, Colic M. The response of human dendritic cells to co-ligation of pattern-recognition receptors. Immunol Res. 2012;52:20-33.
19. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factorbeta are essential for the differentiation of interleukin 17- producing human T helper cells. Nat Immunol. 2007;8:942-949.
20. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-957.
21. Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci. 2008;49:3058-3064.
22. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335:1078-1080.
23. Yavuz S, Elbir Y, Tulunay A, Eksioglu-Demiralp E, Direskeneli H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet's disease etiopathogenesis. Rheumatol Int. 2008;28: 401-406.
24. Slobodin G, Toukan Y, Rosner I, et al. LPS-stimulated production of TNF-alpha by peripheral blood monocytes in patients with Behcet's disease. Clin Rheumatol. 2007;26:764-767.
25. Chamorro S, Garcia-Vallejo JJ, Unger WW, et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol. 2009;183:2984-2994.
26. Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interferon Cytokine Res. 2011;31:733-744.
27. Nishida T, Hirayama K, Nakamura S, Ohno S. Proliferative response of CD8{thorn} gamma delta{thorn} T cells to Streptococcus sanguis in patients with Behcet's disease. Ocul Immunol Inflamm. 1998;6:139-144.
28. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behcet's disease with special emphasis on the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417-424.
29. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behcet's disease. Eur J Dermatol. 2008;18:489-498.
30. Nara K, Kurokawa MS, Chiba S, et al. Involvement of innate immunity in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol. 2008;152:245-251.
31. Do JE, Kwon SY, Park S, Lee ES. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford). 2008;47:840-848.
32. Kirino Y, Takeno M, Watanabe R, et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behcet's disease. Arthritis Res Ther. 2008;10:R16.
33. Myles A, Aggarwal A. Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology (Oxford). 2011;50:481-488.
34. Midgley A, Thorbinson C, Beresford MW. Expression of Tolllike receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology (Oxford). 2012;51:824-832.
35. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233-240.